Giovanna Utano

89133, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Systemic Mastocytosis: Molecular Pathophysiology, WHO Diagnostic Framework, and KIT-Directed Targeted Therapies.

Systemic Mastocytosis: Molecular Pathophysiology, WHO Diagnostic Framework, and KIT-Directed Targeted Therapies.

Journal: Cancers
Published: June 16, 2026

Quality of Life in CAR-T Cell Therapy.

Quality of Life in CAR-T Cell Therapy.

Journal: Hematology reports
Published: April 24, 2026

Menin Inhibition in Acute Myeloid MLL Rearranged Leukemias: A New Target for Precision Care.

Menin Inhibition in Acute Myeloid MLL Rearranged Leukemias: A New Target for Precision Care.

Journal: Cancers
Published: January 20, 2026

Is There a Future for CAR-T Therapy in Acute Myeloid Leukemia?

Is There a Future for CAR-T Therapy in Acute Myeloid Leukemia?

Journal: Cancers
Published: December 02, 2025

Efficacy of Polyvinylpyrrolidone-Zinc Gluconate and Taurine Gel in the Prophylaxis of Oral Mucositis in Adults Undergoing High-Dose Chemotherapy and Allogeneic Stem Cell Transplantation.

Efficacy of Polyvinylpyrrolidone-Zinc Gluconate and Taurine Gel in the Prophylaxis of Oral Mucositis in Adults Undergoing High-Dose Chemotherapy and Allogeneic Stem Cell Transplantation.

Journal: Diseases (Basel, Switzerland)
Published: October 30, 2025

SLAMF7: A Potential Target for CAR T-Cell Therapy in Multiple Myeloma.

SLAMF7: A Potential Target for CAR T-Cell Therapy in Multiple Myeloma.

Journal: Cancers
Published: September 23, 2025

CAR-T Cell Therapies in B-Cell Acute Lymphoblastic Leukemia: Emerging Data and Open Issues.

CAR-T Cell Therapies in B-Cell Acute Lymphoblastic Leukemia: Emerging Data and Open Issues.

Journal: Cancers
Published: August 06, 2025

Treatment Strategies Used in Treating Myelofibrosis: State of the Art.

Treatment Strategies Used in Treating Myelofibrosis: State of the Art.

Journal: Hematology reports
Published: August 29, 2024

First-Line Use of Daratumumab in Patients with Multiple Myeloma Shows Delayed Neutrophil and Platelet Engraftment after Autologous Stem Cell Transplantation: Results from a Real-Life Single-Center Study.

First-Line Use of Daratumumab in Patients with Multiple Myeloma Shows Delayed Neutrophil and Platelet Engraftment after Autologous Stem Cell Transplantation: Results from a Real-Life Single-Center Study.

Journal: Cancers
Published: August 20, 2024

Optimizing maintenance therapy in acute myeloid leukemia: where do we stand in the year 2024?

Optimizing maintenance therapy in acute myeloid leukemia: where do we stand in the year 2024?

Journal: Expert review of hematology
Published: July 17, 2024

Integrating CAR-T cell therapy into the management of DLBCL: what we are learning.

Integrating CAR-T cell therapy into the management of DLBCL: what we are learning.

Journal: Expert opinion on biological therapy
Published: December 11, 2023

The Role of MicroRNA in Graft-Versus-Host-Disease: A Review.

The Role of MicroRNA in Graft-Versus-Host-Disease: A Review.

Journal: Genes
Published: July 18, 2023
Showing 1-12 of 13

Last Updated: 09/26/2026